Adrian Michael Schreyer

Title: Adrian Michael Schreyer: Innovator in Pharmaceutical Chemistry

Introduction

Adrian Michael Schreyer is a notable inventor based in Dundee, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target adenosine receptors.

Latest Patents

Schreyer holds a patent for "Pyrazolopyrimidine compounds as adenosine receptor antagonists." This invention provides a compound of formula (I), or pharmaceutically acceptable ester, amide, carbamate, solvate, or salt thereof. The compound includes a salt of such an ester, amide, or carbamate, wherein R is an optionally substituted phenyl, or an optionally substituted 5- or 6-membered aromatic heterocycle. Additionally, R is an optionally substituted 5- or 6-membered aromatic heterocycle. The patent also covers pharmaceutical compositions comprising a compound of formula (I). He has 1 patent to his name.

Career Highlights

Throughout his career, Schreyer has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Exscientia Ltd. and Evotec International GmbH. His work in these organizations has contributed to advancements in drug discovery and development.

Collaborations

Schreyer has collaborated with several professionals in his field, including Andrew Simon Bell and Stephanie Versluys. These collaborations have likely enhanced his research and innovation efforts.

Conclusion

Adrian Michael Schreyer is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions, particularly in the area of adenosine receptor antagonists, highlight his role in advancing medical science.